ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,492Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1187

$783K Total Retail Price of All Prescriptions

Rank: 56 out of 1187

482 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 3,130 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 264 75 1 3
DIVALPROEX SODIUM 234 0 2 79
OMEPRAZOLE 224 73 3 5
RISPERIDONE 186 0 4 58
ATORVASTATIN CALCIUM 145 56 5 6
CITALOPRAM HBR 140 51 6 45
OLANZAPINE 135 0 7 107
FUROSEMIDE 134 101 8 8
BENZTROPINE MESYLATE 130 0 R 9 133
SIMVASTATIN 127 76 10 1
ABILIFY 124 0 11 155
DIVALPROEX SODIUM ER 121 0 12 144
OXYCODONE HCL 119 0 S2 13 38
METOPROLOL TARTRATE 107 39 14 10
LISINOPRIL 106 79 15 4
SERTRALINE HCL 100 24 16 22
HYDROCHLOROTHIAZIDE 99 31 17 9
ZOLPIDEM TARTRATE 96 49 18 14
POLYETHYLENE GLYCOL 3350 94 22 19 86
AMLODIPINE BESYLATE 94 61 19 2
FLUOXETINE HCL 93 12 21 108
METOPROLOL SUCCINATE 84 50 22 11
RANITIDINE HCL 79 41 23 69
TRAMADOL HCL 79 56 23 28
NEXIUM 77 34 25 15
METFORMIN HCL 76 40 26 7
HALOPERIDOL 69 0 27 136
AZITHROMYCIN 65 45 28 24
LAMOTRIGINE 64 0 29 163
TAMSULOSIN HCL 62 22 30 29
ZETIA 61 26 31 64
FLUTICASONE PROPIONATE 60 0 32 31
CRESTOR 60 32 32 16
TOPIRAMATE 60 0 32 161
ZIPRASIDONE HCL 57 0 35 250
CARVEDILOL 56 37 36 19
ATENOLOL 55 40 37 18
ESCITALOPRAM OXALATE 54 12 38 51
AMOXICILLIN 52 27 39 97
PROAIR HFA 52 11 39 41
CALCITRIOL 50 19 41 320
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.